Loading...
WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease
Clinical trials to improve day-to-day function in Huntington disease (HD) require accurate outcome measures. The DSM-5 recommends the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 for use in neuropsychiatric disorders. The DSM-5 also states proxy measures may be useful when c...
Na minha lista:
Udgivet i: | Eur J Hum Genet |
---|---|
Main Authors: | , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4350592/ https://ncbi.nlm.nih.gov/pubmed/24327189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.275 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|